D. Bromage

Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium

D. Yellon, S. Davidson, D. Bromage, 2014, Pharmacology & therapeutics.

Stromal cell-derived factor-1α signals via the endothelium to protect the heart against ischaemia-reperfusion injury

O. Ziff, D. Yellon, S. Davidson, 2019, Journal of molecular and cellular cardiology.

Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy

O. Ziff, D. Yellon, S. Davidson, 2017, Cardiovascular research.

A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies

D. Yellon, S. Davidson, D. Bromage, 2017, PloS one.

The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology

Arjun K. Ghosh, H. Bøtker, B. Ibáñez, 2018, Basic Research in Cardiology.

Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment

O. Ziff, F. Ruschitzka, D. Francis, 2020, BMC Medicine.

Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis

O. Ziff, D. Yellon, X. Rosselló, 2016, Cardiovascular research.